Table 15.5b

Steroid Avoidance Rate at Discharge, 1997 to 2006

Recipients of Living Donor Livers

Discharge Regimen Year of Transplant
1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
Total Patients 70 71 192 326 449 307 282 292 288 258
Steroids Avoided 3 6 13 30 40 25 63 64 69 73
Rate 4.3% 8.5% 6.8% 9.2% 8.9% 8.1% 22.3% 21.9% 24.0% 28.3%
CyA Patients 11 8 14 16 16 6 9 - 1 1
Steroids Avoided 0 2 4 1 8 1 1 - 0 0
Rate 0.0% 25.0% 28.6% 6.3% 50.0% 16.7% 11.1% - 0.0% 0.0%
Tac Patients 25 27 96 126 156 123 101 105 103 104
Steroids Avoided 2 2 4 7 11 18 27 35 36 31
Rate 8.0% 7.4% 4.2% 5.6% 7.1% 14.6% 26.7% 33.3% 35.0% 29.8%
CyA+MMF Patients 6 6 13 17 22 22 18 18 9 4
Steroids Avoided 0 0 1 0 0 2 2 1 2 2
Rate 0.0% 0.0% 7.7% 0.0% 0.0% 9.1% 11.1% 5.6% 22.2% 50.0%
Tac+MMF Patients 7 24 50 111 172 118 136 142 151 141
Steroids Avoided 0 1 3 5 2 3 28 24 23 39
Rate 0.0% 4.2% 6.0% 4.5% 1.2% 2.5% 20.6% 16.9% 15.2% 27.7%
CyA+Aza Patients 11 1 3 3 2 4 3 2 2 -
Steroids Avoided 0 0 0 0 0 0 1 0 0 -
Rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 33.3% 0.0% 0.0% -
Tac+Aza Patients 2 - 4 2 - 3 - - 1 -
Steroids Avoided 0 - 0 0 - 0 - - 1 -
Rate 0.0% - 0.0% 0.0% - 0.0% - - 100.0% -
Siro+MMF Patients - - - 1 5 2 1 1 1 -
Steroids Avoided - - - 0 0 0 0 0 0 -
Rate - - - 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -
CyA+Siro Patients - - - 7 6 1 - 1 - -
Steroids Avoided - - - 4 3 0 - 0 - -
Rate - - - 57.1% 50.0% 0.0% - 0.0% - -
Tac+Siro Patients - - - 20 36 11 1 5 1 2
Steroids Avoided - - - 8 11 0 0 1 0 0
Rate - - - 40.0% 30.6% 0.0% 0.0% 20.0% 0.0% 0.0%
Other Regimen Patients 8 5 12 23 34 17 13 18 19 6
Steroids Avoided 1 1 1 5 5 1 4 3 7 1
Rate 12.5% 20.0% 8.3% 21.7% 14.7% 5.9% 30.8% 16.7% 36.8% 16.7%


Source: OPTN/SRTR Data as of May 1, 2007.

Includes patients receiving first transplants of any organ with a functioning graft at discharge and any immunosuppressive drug use recorded at discharge.

CyA: Cyclosporine; Tac: Tacrolimus; MMF: Include MMF(Mycophenolate Mofetil) and MPA(Mycophenolate Sodium); Aza: Azathioprine; Siro: Sirolimus.